Simultaneously, our previous studies also have proved the epigenetic style of GPX3 in AML and chronic myeloid leukemia (CML), and further disclosed that hypermethylation of GPX3 promoter was a prognostically adverse indicator in AML 21, 22, 23. This evidence concerns the gene GPX3 and acute myeloid leukemia.